» Articles » PMID: 31530089

Diversity, Mechanisms, and Significance of Macrophage Plasticity

Overview
Journal Annu Rev Pathol
Publisher Annual Reviews
Specialty Pathology
Date 2019 Sep 19
PMID 31530089
Citations 787
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages are a diverse set of cells present in all body compartments. This diversity is imprinted by their ontogenetic origin (embryonal versus adult bone marrow-derived cells); the organ context; by their activation or deactivation by various signals in the contexts of microbial invasion, tissue damage, and metabolic derangement; and by polarization of adaptive T cell responses. Classic adaptive responses of macrophages include tolerance, priming, and a wide spectrum of activation states, including M1, M2, or M2-like. Moreover, macrophages can retain long-term imprinting of microbial encounters (trained innate immunity). Single-cell analysis of mononuclear phagocytes in health and disease has added a new dimension to our understanding of the diversity of macrophage differentiation and activation. Epigenetic landscapes, transcription factors, and microRNA networks underlie the adaptability of macrophages to different environmental cues. Macrophage plasticity, an essential component of chronic inflammation, and its involvement in diverse human diseases, most notably cancer, is discussed here as a paradigm.

Citing Articles

Radiation-induced lung injury: from mechanism to prognosis and drug therapy.

Wang S, Xu D, Xiao L, Liu B, Yuan X Radiat Oncol. 2025; 20(1):39.

PMID: 40082925 PMC: 11907960. DOI: 10.1186/s13014-025-02617-8.


Identification of Energy Metabolism-Related Subtypes and Diagnostic Biomarkers for Osteoarthritis by Integrating Bioinformatics and Machine Learning.

Xu S, Ye J, Cai X J Multidiscip Healthc. 2025; 18:1353-1369.

PMID: 40060994 PMC: 11890432. DOI: 10.2147/JMDH.S510308.


Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.

Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y Signal Transduct Target Ther. 2025; 10(1):93.

PMID: 40055311 PMC: 11889221. DOI: 10.1038/s41392-025-02124-y.


Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets.

Suliman M, Saleh R, Chandra M, Rasool K, Jabir M, Jawad S Med Oncol. 2025; 42(4):91.

PMID: 40048034 DOI: 10.1007/s12032-025-02643-2.


Bioactive lipid signaling and lipidomics in macrophage polarization: Impact on inflammation and immune regulation.

Rodriguez J, Casas J, Balboa M, Balsinde J Front Immunol. 2025; 16:1550500.

PMID: 40028333 PMC: 11867965. DOI: 10.3389/fimmu.2025.1550500.


References
1.
Udalova I, Mantovani A, Feldmann M . Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol. 2016; 12(8):472-85. DOI: 10.1038/nrrheum.2016.91. View

2.
Ginhoux F, Guilliams M . Tissue-Resident Macrophage Ontogeny and Homeostasis. Immunity. 2016; 44(3):439-449. DOI: 10.1016/j.immuni.2016.02.024. View

3.
Foster S, Hargreaves D, Medzhitov R . Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 2007; 447(7147):972-8. DOI: 10.1038/nature05836. View

4.
Viitala M, Virtakoivu R, Tadayon S, Rannikko J, Jalkanen S, Hollmen M . Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8 T-cell Response against Immunosuppressive Tumors. Clin Cancer Res. 2019; 25(11):3289-3303. DOI: 10.1158/1078-0432.CCR-18-3016. View

5.
Molgora M, Supino D, Mavilio D, Santoni A, Moretta L, Mantovani A . The yin-yang of the interaction between myelomonocytic cells and NK cells. Scand J Immunol. 2018; 88(3):e12705. PMC: 6485394. DOI: 10.1111/sji.12705. View